The effect of exaprolol (MG 8823) on epicardial ST-segment changes in a feline model of acute myocardial ischaemiaPARRATT, J. R; UDVARY, E.British journal of pharmacology. 1983, Vol 80, Num 1, pp 95-105, issn 0007-1188Article

The use of the EEG for assessment of vigilance changes caused by beta-blockersMATOUSEK, M; HJALMARSON, A; KOCH, J et al.Neuropsychobiology. 1984, Vol 12, Num 1, pp 55-59, issn 0302-282XArticle

Effects of beta-receptor blockers in pharmacology EEGESCHMANN, G; IRRGANG, V; RÜTHER, E et al.Neuropsychobiology. 1983, Vol 10, Num 2-3, pp 190-192, issn 0302-282XArticle

Le point sur les effets indésirables des bêta-bloquants = Beta blocking agent toxicityCHEYMOL, G; BIOUR, M.La Vie médicale (1969). 1985, Vol 66, Num 4, pp 157-160, issn 0042-5583, 3 p.Article

ADP-induced platelet aggregation and metoprolol treatment of myocardial infarction patients: a controlled studyVILEN, L; KUTTI, J; SWEDBERG, K et al.Acta medica Scandinavica. 1985, Vol 217, Num 1, pp 15-20, issn 0001-6101Article

Carbon-13 nuclear magnetic resonance of some new β-blockers. IABOUL-ENEIN, H. Y; HASSAN, M. M. A; JADO, A. I et al.Spectroscopy letters. 1983, Vol 16, Num 3, pp 151-158, issn 0038-7010Article

Effect of the sialylation state of α₁-acid glycoprotein on propranolol bindingPRIMOZIC, S; MCNAMARA, P. J.Journal of pharmaceutical sciences. 1985, Vol 74, Num 4, pp 473-475, issn 0022-3549Article

Revised HPLC determination of atenolol in plasma and urineGILLILAN, R. B; MASON, W. D.Analytical letters. 1983, Vol 16, Num 12, pp 941-949, issn 0003-2719Article

Recent chemical developments in the field of beta adrenoceptor blocking drugsKÖPPE, H. G.Progress in clinical biochemistry and medicine. 1986, Vol 3, pp 29-72, issn 0177-8757Article

Increased portal venous resistance hinders portal pressure reduction during the administration of β-adrenergic blocking agents in a portal hypertensive modelKROEGER, R. J; GROSZMANN, R. J.Hepatology (Baltimore, Md.). 1985, Vol 5, Num 1, pp 97-101, issn 0270-9139Article

Role of β₂-adrenoceptor blockade and circulating adrenaline level for the pressor responses to β-adrenoceptor blocking drugs in ratsHIMORI, N; ISHIMORI, T; SHIRATSUCHI, K et al.Naunyn-Schmiedeberg's archives of pharmacology. 1984, Vol 325, Num 4, pp 314-319, issn 0028-1298Article

The psychological side effects of acebutolol and atenololLEWIS, M. J; JONES, D. M; DART, A. M et al.British journal of clinical pharmacology. 1984, Vol 17, Num 3, pp 364-366, issn 0306-5251Article

Variations in Pharmacology of β-Blockers May Contribute to Heterogeneous Results in Trials of Perioperative β-BlockadeBADGETT, Robert G; LAWRENCE, Valerie A; COHN, Steven L et al.Anesthesiology (Philadelphia). 2010, Vol 113, Num 3, pp 585-592, issn 0003-3022, 8 p.Article

Chiral chromatographic separation of β-blockersAGRAWAL, Y. K; PATEL, R. N.Journal of chromatography. B. 2005, Vol 820, Num 1, pp 23-31, issn 1570-0232, 9 p.Article

The analysis of atenolol in plasma using an automated sample preparation techniqueDALE, A. D; TURNER, S. E.Journal of pharmaceutical and biomedical analysis. 1990, Vol 8, Num 8-12, pp 1055-1058, issn 0731-7085, 4 p.Conference Paper

Pharmacokinetic parameters of bevantolol in volunteersVERMEIJ, P; VAN BRUMMELEN, P.European journal of clinical pharmacology. 1986, Vol 30, Num 3, pp 375-377, issn 0031-6970Article

Beta blocker overdose with propranolol and with atenololWEINSTEIN, R. S; COLE, S; KNASTER, H. B et al.Annals of emergency medicine. 1985, Vol 14, Num 2, pp 161-163, issn 0196-0644Article

Measuring side-effects of β-adrenoceptor antagonists: a comparison of two methodsLEWIS, R. V; JACKSON, P. R; RAMSAY, L. E et al.British journal of clinical pharmacology. 1985, Vol 19, Num 6, pp 826-828, issn 0306-5251Article

Effects of the (±)-, (+)- and (-) forms of propranolol, timolol and metoprolol on noradrenergic transmission in the rat isolated right ventricleBRADLEY, L; DOGGRELL, S. A.Archives internationales de pharmacodynamie et de thérapie. 1984, Vol 270, Num 1, pp 61-78, issn 0003-9780Article

Oxyfedrine and propranolol: a comparative experimental approach to protect myocardium against isoprenaline-induced myocardial necrosisSETH, S. D; GUPTA, M. P; GUPTA, M et al.Arzneimittel-Forschung. 1984, Vol 34, Num 6, pp 678-683, issn 0004-4172Article

Analysis of oxprenolol in formulations by high-performance liquid chromatographyADNAN EL-YAZIGI.Journal of pharmaceutical sciences. 1984, Vol 73, Num 6, pp 751-754, issn 0022-3549Article

Comparison of the effects of prizidilol and propranolol on renal haemodynamics at rest and during exerciseMALINI, P. L; STROCCHI, E; AMBROSIONI, E et al.British journal of clinical pharmacology. 1984, Vol 17, Num 3, pp 251-255, issn 0306-5251Article

Les bêta-bloquants et la fonction rénale = Beta blocking drugs and renal functionFILLASTRE, J. P; GODIN, M.LARC médical. 1983, Vol 3, Num 7, pp 508-512, issn 0242-9462Article

The pharmacoeconomics of peri-operative beta-blocker therapyBICCARD, B. M; SEAR, J. W; FOËX, P et al.Anaesthesia. 2006, Vol 61, Num 1, pp 4-8, issn 0003-2409, 5 p.Article

Use of 4-(N,N-dimethylaminosulphonyl)-7-fluoro-2,1,3-benzoxadiazole as a labelling reagent for peroxyoxalate chemiluminescence detection and its application to the determination of the β-blocker metoprolol in serum by high-performance liquid chromatographyUZU, S; IMAI, K; NAKASHIMA, K et al.Analyst (London. 1877. Print). 1991, Vol 116, Num 12, pp 1353-1357, issn 0003-2654Article